Indivior NJ postings 2020

Quote

anonymous

Guest
Hi. Some positions in NJ have posted and I’m interested. They didn’t specify which specialty I’d be selling (schizophrenia or addiction). The posts on here are telling me to stay away from this company but that seems to be the case with every company on CP. We all know that your manager dictates for the most part how happy you are with a company so I’m just wondering if anyone can give me some info on the NJ management landscape. Thanks and Happy New Year.

PS. I’m open to any and all information on the company, products, pros and cons of company. Good, bad or ugly! Thanks
 












anonymous said:
Hi. Some positions in NJ have posted and I’m interested. They didn’t specify which specialty I’d be selling (schizophrenia or addiction). The posts on here are telling me to stay away from this company but that seems to be the case with every company on CP. We all know that your manager dictates for the most part how happy you are with a company so I’m just wondering if anyone can give me some info on the NJ management landscape. Thanks and Happy New Year.

PS. I’m open to any and all information on the company, products, pros and cons of company. Good, bad or ugly! Thanks
Click to expand...

Do your research very thoroughly. This company has many more issues and challenges than your average pharma company as outlined on many of these threads. This should be a "job of last resort".
Best of luck to you.
 






Do your research is correct. Ask how the territory has been performing? Many managers would blame the previous CS and it could/could not be the case. Ask what it would take for this territory to be a top performer. Also inquire about DOJ lawsuit
 


















From what I see, the senior sales leadership are not on their game. They don't get it at all. They haven't figured out that their assessments and goal setting for individual territories with the addiction product is way off. Uptake of the product is unique in every territory, but if the market doesn't grow on pace with their big pharma cookie cutter mentality then it's the sales rep's fault because they "can't sell" which in most cases is not the truth at all. The product is hard to get, either in dealing with insurance or specialty pharmacy problems, and customers often don't want to deal with it. As long as the current oblivious leadership is in place there will continue to be high turnover.
 






anonymous said:
From what I see, the senior sales leadership are not on their game. They don't get it at all. They haven't figured out that their assessments and goal setting for individual territories with the addiction product is way off. Uptake of the product is unique in every territory, but if the market doesn't grow on pace with their big pharma cookie cutter mentality then it's the sales rep's fault because they "can't sell" which in most cases is not the truth at all. The product is hard to get, either in dealing with insurance or specialty pharmacy problems, and customers often don't want to deal with it. As long as the current oblivious leadership is in place there will continue to be high turnover.
Click to expand...
 






anonymous said:
From what I see, the senior sales leadership are not on their game. They don't get it at all. They haven't figured out that their assessments and goal setting for individual territories with the addiction product is way off. Uptake of the product is unique in every territory, but if the market doesn't grow on pace with their big pharma cookie cutter mentality then it's the sales rep's fault because they "can't sell" which in most cases is not the truth at all. The product is hard to get, either in dealing with insurance or specialty pharmacy problems, and customers often don't want to deal with it. As long as the current oblivious leadership is in place there will continue to be high turnover.
Click to expand...
TRUTH
 
























Top Bottom
Back
Quote